Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $42.38M.
ENTERPRISE VALUE (EV)
$42.38M
OKYO Pharma Limited
Market Cap
$56.98M
Enterprise Value (EV)
$42.38M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| OKYO Pharma Limited (OKYO) | $56.98M | $42.38M |
| Talphera, Inc. (TLPH)vs › | $57.09M | $56.35M |
| MiNK Therapeutics, Inc. (INKT)vs › | $57.69M | $48.88M |
| PDS Biotechnology Corporation (PDSB)vs › | $58.16M | $56.93M |
| Boundless Bio, Inc. (BOLD)vs › | $58.66M | $38.45M |
| Connect Biopharma Holdings Limited (CNTB)vs › | $59.25M | $32.83M |
| Adicet Bio, Inc. (ACET)vs › | $59.36M | $39.08M |
| Spectral AI, Inc. (MDAI)vs › | $54.10M | $56.38M |
| Xilio Therapeutics, Inc. (XLO)vs › | $60.03M | N/A |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.21M | $56.54M |
Market Cap
$56.98M
Total Debt
$0.00
Cash
$14.59M
Enterprise Value
$42.38M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
